Cardiovascular and Renal Outcomes of Incretin-based Therapies: A Review of Recent Clinical Trials

por Kyriakos, Georgios, Quiles-Sanchez, Lourdes V., Garmpi, Anna, Farmaki, Paraskevi, Kyre, Konstantina, Gkogkos, Spyridon, Savvanis, Spyridon, Memi, Eleni
Publicado 2020

SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study

por Kyriakos, Georgios, Quiles-Sanchez, Lourdes V., Garmpi, Anna, Farmaki, Paraskevi, Kyre, Konstantina, Savvanis, Spyridon, Antoniou, Vasileios K., Memi, Eleni
Publicado 2020